BR0315495A - Composição para reduzir ingestão calórica - Google Patents

Composição para reduzir ingestão calórica

Info

Publication number
BR0315495A
BR0315495A BR0315495-5A BR0315495A BR0315495A BR 0315495 A BR0315495 A BR 0315495A BR 0315495 A BR0315495 A BR 0315495A BR 0315495 A BR0315495 A BR 0315495A
Authority
BR
Brazil
Prior art keywords
caloric intake
composition
ingestion
meal
effective amount
Prior art date
Application number
BR0315495-5A
Other languages
English (en)
Inventor
Robert Portman
Original Assignee
Pacific Health Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Health Lab Inc filed Critical Pacific Health Lab Inc
Publication of BR0315495A publication Critical patent/BR0315495A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"COMPOSIçãO PARA REDUZIR INGESTãO CALóRICA". A presente invenção refere-se a uma composição para reduzir ingestão calórica estimulando a liberação de colecistocinina seguindo ingestão compreendendo glicomacropeptídeo e excipientes adequados para ingestão na ausência substancial dsimilares agentes conhecidos estimular a liberação de colecistocinina seguindo ingestão. As composições em questão podem adicionalmente conter outro agente que reduz ingestão calórica por um modo de ação diferente que estimular a liberação de colecistocinina. A invenção também compreende um método de alcançar uma redução de ingestão calórica levando um indivíduo em necessidade desta ingerir uma quantidade eficaz das composições descritas com uma refeição ou até cerca de dez minutos antes de uma refeição. Uma quantidade eficaz das composições em questão a ser consumidas antes ou com uma refeição tipicamente fornecerá de cerca de 0,2 a cerca de 3 gramas de glicomacropeptídeo puro.
BR0315495-5A 2002-10-18 2003-10-17 Composição para reduzir ingestão calórica BR0315495A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/274,071 US20040077530A1 (en) 2002-10-18 2002-10-18 Composition for reducing caloric intake
PCT/US2003/033021 WO2004034813A2 (en) 2002-10-18 2003-10-17 Composition for reducing caloric intake

Publications (1)

Publication Number Publication Date
BR0315495A true BR0315495A (pt) 2005-08-23

Family

ID=32092954

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315495-5A BR0315495A (pt) 2002-10-18 2003-10-17 Composição para reduzir ingestão calórica

Country Status (9)

Country Link
US (1) US20040077530A1 (pt)
EP (1) EP1551442A2 (pt)
JP (1) JP2006503099A (pt)
CN (1) CN1723033A (pt)
AU (1) AU2003301261A1 (pt)
BR (1) BR0315495A (pt)
CA (1) CA2502794A1 (pt)
MX (1) MXPA05004108A (pt)
WO (1) WO2004034813A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9307991B2 (en) 2002-08-22 2016-04-12 Ams Research, Llc Anastomosis device and related methods
US20060013903A1 (en) * 2004-07-16 2006-01-19 Timothy Romero Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss
BRPI0508181A (pt) * 2004-04-02 2007-08-07 Univ Tennessee Res Foundation componentes de laticìnio eficazes para a perda de gordura
US7968138B2 (en) 2004-07-23 2011-06-28 Arnold Nerenberg Food sweetener
MX2007012699A (es) * 2005-04-11 2008-01-11 Univ Tennessee Res Foundation Componenetes lacteos estables eficaces para la perdida de grasa.
JP4180645B2 (ja) 2005-09-30 2008-11-12 森永乳業株式会社 グルカゴン様ペプチド−１分泌促進剤及び食後血糖値上昇抑制剤
AU2008282445A1 (en) * 2007-07-27 2009-02-05 Gilmore Sports Ii, Llc Exercise performance and recovery formulations
WO2009112036A2 (en) * 2008-03-12 2009-09-17 Arla Foods Amba Whey protein beverages having reduced astringency
RU2010148756A (ru) * 2008-04-30 2012-06-10 Нестек С.А. (Ch) Пищевая композиция, вызывающая чувство сырости
CN102481338A (zh) * 2009-06-12 2012-05-30 威斯康星校友研究基金会 用于苯丙酮尿症和其他代谢疾病的营养控制的糖巨肽药用食物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
JPH0699321B2 (ja) * 1990-01-22 1994-12-07 不二製油株式会社 食欲抑制剤及びこれを含有する食品
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
US5670201A (en) * 1991-06-21 1997-09-23 Snow Brand Milk Co., Ltd. Low allergenic nutrient composition and method of using same
FR2758143B1 (fr) * 1997-01-07 1999-02-19 Laphal Laboratoire De Pharmaco Inhibiteurs specifiques de la lipase pancreatique et leurs applications
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5932561A (en) * 1997-10-24 1999-08-03 Rexall Sundown, Inc. Dietary composition with lipid binding properties for weight management and serum lipid reduction
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US6429190B1 (en) * 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
US6420350B1 (en) * 2001-01-18 2002-07-16 Goen Group, Inc. Weight loss product
US6797290B2 (en) * 2001-09-17 2004-09-28 Mcneil-Ppc, Inc. Compositions for appetite control and related methods

Also Published As

Publication number Publication date
WO2004034813A3 (en) 2004-09-30
WO2004034813A2 (en) 2004-04-29
CA2502794A1 (en) 2004-04-29
MXPA05004108A (es) 2005-10-05
CN1723033A (zh) 2006-01-18
US20040077530A1 (en) 2004-04-22
EP1551442A2 (en) 2005-07-13
AU2003301261A1 (en) 2004-05-04
JP2006503099A (ja) 2006-01-26

Similar Documents

Publication Publication Date Title
CA2286552C (en) Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
BR0306919A (pt) Métodos para reduzir ou suprimir a efetividade adversa da terapia de l-dopa e/ou do agonista da dopamina, e para tratamento moderado de l-dopa, composição para tratamento moderado de l-dopa, método para tratar doença de parkinson e/ou complicações motoras de l-dopa, composição para o tratamento da doença de parkinson, e, métodos para prolongar o tratamento eficaz da doença de parkinson, e para tratar os distúrbios de movimento
UY27438A1 (es) Composición farmaceútica que comprende un conjugado oligómero-farmaco insulina, método para tratar deficiencia de insulina en un sujeto, método para proveer una composición farmacéutica.
AR109995A2 (es) Método para inhibir la resorción ósea
US20100330198A1 (en) Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
PE19496A1 (es) Formulacion de analogo de insulina humana
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
DK0798971T3 (da) Forøgelse af creatin- og glycogenkoncentration i muskler
DE69314035D1 (de) Verbesserte aushalten - und rehydratationzusammenstellung
BR0311939A (pt) composição farmacêutica, método para tratar inflamação em um mamìfero e uso de uma citocina protetora de tecido orgánico
BR0111800A (pt) Combinações de inibidores de depeptidil peptidase iv e outros agentes antidiabéticos para o tratamento de diabete mellitus
BR0008059A (pt) Composições de valdecoxib
NZ332689A (en) Using interferon to treat autoimmune, mycobacterial or neurodegenerative disease
EA200101089A1 (ru) Новый способ лечения
BR0315495A (pt) Composição para reduzir ingestão calórica
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
WO2002047614A3 (en) Nutritional composition for improving the efficacy of a lipase inhibitor
BRPI0507895A (pt) composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
BR9914419A (pt) Terapia para melhoria da percepção
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
BRPI0413410A (pt) co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
BRPI0413404A (pt) composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif
BR0308584A (pt) Composição farmacêutica androgênica e método para tratamento de depressão

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]